Delivery Order SPE2DB20D1004-SPE2DB24FG6J3

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,793.11 firm fixed-price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of July 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.50 firm fixed-price delivery order is for TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $7,553.35 firm fixed-price delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,424.72 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $1,102.53 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,504.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical product. It has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,570.32 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,810.44 delivery order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,914.41 firm fixed-price contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,813.26 firm fixed-price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG6J3
    Delivery Order

This is a $1,397.48 delivery order (contract type: firm fixed price) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of August 12, 2024.

AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:03 PM